FormWeb • cidofovir

IHS FormWeb

Approved Formulary

Staff Telephone Numbers

Webpage Links

Add Formweb to your mobile device

Android iOS

Search results for:

cidofovir

cidofovir

Brand names: Vistide

Form	Strength
SOLUTION, INTRAVENOUS	75 mg/mL

Display Nucleosides and Nucleotides Class: 081832

Medication comments:

USP <800> Hazardous Drug Assessment of Risk (AOR)
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances. The following outlines must be followed.
generic (Brand) Route [Packaging: Manufacturer ⇒ Dispense]		NIOSH Group
cidofovir (Vistide) IV [n/a]		Non - Antineoplastic
Pharmacy: Receiving / Storage / Preparation Exposure Risk: low	• Handling/preparation PPE Requirements: Single CX gloves , gown , CSTD
	• Receiving from Distributor: Standard
	• Pharmacy Storage Area: IV CSTD Area
	• Packaging/Reconstitution Location: n/a
	• Compounding (Non-Sterile/Sterile) Location: Ideal: Positive pressure room Required: Med Prep Area with Immediate Use Preparation standards
	• Omnicell Load: No
Transport	• Transport (dose is placed inside a plastic sealable bag): Double Bag; single CX gloves
Nursing: Storage / Admin. Exposure Risk: low	• Handling/administration PPE Requirements: Double CX gloves , gown , CSTD
	• Storage of Finished dose in Nursing Area/Procedural Area: Picked up from Pharmacy
	• Signage on Patient Door Required: Yes
	• Manipulation of Dosage Form: n/a
	• Special Manipulation for Administration: n/a
Disposal / Spills	• Disposal of Drug Waste: Full- black bin , trace- yellow bin
	• Disposol of Used PPE: yellow bin
	• Spill management: Manage like antineoplastic agents
Reason for exemption of USP<800> Containment Requirements: NIOSH recommends PPE + CSTD for preparation. PPE + CTSD requires for administration. Pregnancy Category C. MSHG recommends following NIOSH. Also notes, if cidofovir contacts the skin, wash membranes and flush thoroughly with water. Risks are related to systemic absorption.

Last updated: Apr. 4, 2024

Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug / Assessment of Risk
Black Box Warnings Nephrotoxicity; neutropenia

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556

This site is intended for the staff of Iredell Memorial Hospital.
While others may view accessible pages, Iredell Memorial Hospital makes no warranty, express or implied,
as to the use of this information outside of Iredell Memorial Hospital.
The content of this policy and procedure document serves as guidance to the delivery of quality patient care.
Care providers are expected to exercise critical thinking and situational awareness skills,
and in specific situations to take such action as is necessary for the delivery of quality patient care.